Form 4 for WST West Pharmaceutical Services
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001127602-25-006135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-20 | 2025-02-18 | WST | Birkett Bernard | SVP, CFO | F - Tax | $211.00 | -273.37 | 7,431 | -4% | -$57.7K |
| DM | 2025-02-20 | 2025-02-18 | WST | Birkett Bernard | SVP, CFO | M - OptEx | $211.00 | +904.33 | 7,669 | +13% | +$190.8K |
| DM | 2025-02-20 | 2025-02-18 | WST | Birkett Bernard | SVP, CFO | A - Grant | $0.00 | +5,760 | 1,740 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | F | D | 35.61 | $211.00 | 7,520.38 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-18 | M | A | 124.98 | $211.00 | 7,555.99 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-18 | F | D | 237.76 | $211.00 | 7,431.01 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-18 | M | A | 779.35 | $211.00 | 7,668.77 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-02-18 | A | A | 4,020 | $0.00 | 4,020 | D | $211.00 · 2026-02-18 to 2035-02-18 | 4,020 Common Stock | (F1) This award vests in four equal installments beginning on February 18, 2026. |
| 6 | Derivative | Rst. Stock Unit | 2025-02-18 | A | A | 1,740 | $0.00 | 1,740 | D | $0.00 · — to — | 1,740 Common Stock | (F1) This award vests in four equal installments beginning on February 18, 2026. |